Alimera Sciences Inc Revenue per Employee (ALIM), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Alimera Sciences Inc  (NASDAQ: ALIM)
 

Alimera Sciences Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 52.92% in the second quarter 2024, year on year to cumulative value of $98 million, Alimera Sciences Inc's revenue per employee grew on a trailing twelve months basis to $ 616,887. The productivity of Alimera Sciences Inc's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 75 other companies have achieved higher revenue per employee. While Alimera Sciences Inc's total ranking has deteriorated compared to the previous quarter from 0 to 713. Alimera Sciences Inc has 159 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALIM Revenue per Employee (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Revenue Change 52.92 % 67.27 % 89.98 % 66.25 % 17.18 %
Sales per Employee (TTM) $ 616,887 559,931 502,623 423,233 366,579
ALIM's Total Ranking # 713 # 0 # 0 # 0 # 0
Seq. Revenue Change 15.5 % -14.99 % 17.9 % 32.1 % 26.33 %

ALIM Company Profile >> Back to ALIM Efficiency Comparisons >> Compare ALIM Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 38
Healthcare Sector # 76
Overall Market # 713

Revenue per Employee Statistics
High Average Low
$ 980,850 $ 473,495 $ 102,770
(Jun 30 2024)   (March 31, 2015)



Financial Statements
Alimera Sciences Inc's Revenue MRQ $ 26 Millions Visit ALIM's Income Statement
Alimera Sciences Inc's Revenues TTM $ 98 Millions Visit ALIM's aggregate revenue growth
What are ALIM's Sales? Visit ALIM's Sales by Segment




Other Ratios
Alimera Sciences Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ALIM's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ALIM's Competitors
Revenue per Employee for ALIM's Suppliers
Revenue per Employee for ALIM's Customers

You may also want to know
ALIM's Sales Growth Rates ALIM's Pe Price to earnings ratio ALIM's Receivables Turnover Ratio ALIM's Stock Quote
ALIM's Net Income Growth Rates ALIM's Ps Price to Sales ratio ALIM's Sales per Employee ALIM's Asset Turnover Ratio
ALIM's Net Margin ALIM's Pb Price to Book ratio ALIM's Financial Strength Ratios ALIM's Dividend Payout Ratio
Date modified: 2026-06-22T14:32:38+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2024Number of Employees Jun 30 2024
Moderna Inc   1,074,468.09 $ 5,050.000  Million 4,700 
Neurocrine Biosciences Inc   1,059,750.00 $ 2,119.500  Million 2,000 
Fortress Biotech Inc   1,059,282.05 $ 82.624  Million 78 
G1 Therapeutics Inc   1,058,090.91 $ 58.195  Million 55 
Heron Therapeutics Inc   1,056,984.37 $ 135.294  Million 128 
Agile Therapeutics Inc  1,038,000.00 $ 19.722  Million 19 
Whitehawk Therapeutics Inc   1,035,521.74 $ 23.817  Million 23 
Voyager Therapeutics Inc   1,019,638.30 $ 143.769  Million 141 
Elite Pharmaceuticals Inc   1,016,635.78 $ 66.081  Million 65 
Integrated Biopharma Inc  997,680.00 $ 49.884  Million 50 
Verve Therapeutics Inc   983,238.10 $ 20.648  Million 21 
Molecular Templates Inc   972,693.55 $ 60.307  Million 62 
Supernus Pharmaceuticals inc   966,507.67 $ 630.163  Million 652 
Abbvie Inc   964,912.28 $ 55,000.000  Million 57,000 
Esperion Therapeutics Inc   944,857.14 $ 277.788  Million 294 
Cidara Therapeutics Inc   942,840.58 $ 65.056  Million 69 
Evoke Pharma Inc   940,713.75 $ 7.526  Million 8 
Alnylam Pharmaceuticals Inc   937,762.40 $ 2,344.406  Million 2,500 
Kiniksa Pharmaceuticals International Plc  926,038.25 $ 338.930  Million 366 
Prophase Labs Inc   925,210.53 $ 17.579  Million 19 
Therapeuticsmd Inc   917,000.00 $ 0.917  Million 1 
Masimo Corp  916,363.64 $ 2,016.000  Million 2,200 
Tvardi Therapeutics Inc   916,333.33 $ 10.996  Million 12 
Ptc Therapeutics inc   908,631.69 $ 900.454  Million 991 
Dynavax Technologies Corporation  904,345.45 $ 248.695  Million 275 
Akebia Therapeutics Inc   898,840.21 $ 174.375  Million 194 
Elutia Inc   898,384.62 $ 23.358  Million 26 
Lifevantage Corp  895,623.32 $ 199.724  Million 223 
Amicus Therapeutics inc   888,221.14 $ 453.881  Million 511 
Biocryst Pharmaceuticals Inc   878,703.45 $ 382.236  Million 435 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.